EU Shipping & Regulation Guide

Uptide ships from the Netherlands. Research peptides sold as laboratory reference materials are not classified as controlled substances under the Opiumwet. EU medical product regulations (AMG equivalent: Geneesmiddelenwet) apply to products marketed for therapeutic use — Uptide products are sold exclusively for research and are not marketed as medicines.

• Research peptides not listed on the Opiumwet are not controlled substances.
• Not marketed as medicines, so Geneesmiddelenwet does not apply.
• Purchasing for personal therapeutic use falls on the buyer's legal responsibility.

Germany applies the Arzneimittelgesetz (AMG) strictly. A compound can be classified as a medicine if it is intended for therapeutic use or has an implied therapeutic function — even without explicit marketing claims. Purchasing peptides for anything other than genuine scientific research creates legal risk for the buyer. We ship to Germany only for legitimate research purposes.

• AMG §2 classifies substances by intended use — if therapeutic intent is implied, AMG applies.
• Tirzepatide (Mounjaro®) is an approved prescription drug in Germany — buyers must confirm research purpose.
• GHRP peptides are not separately scheduled but their research use must be documented.
• Melanotan II has been subject to enforcement action in Germany — we do not ship MT-II to Germany.

Belgium's FAMHP (Federal Agency for Medicines and Health Products) regulates medicines, but research compounds not marketed as medicines and not on the controlled substances list fall outside their scope. Most peptides in our catalogue can be ordered for research purposes.

• FAMHP jurisdiction covers medicines — compounds marketed only for research are outside scope.
• Belgian customs may query shipments — attach proof of research purpose if requested.

France's ANSM (Agence nationale de sécurité du médicament) has a broad interpretation of what constitutes a médicament. Compounds that could be considered to have a pharmacological effect may fall under pharmaceutical regulation even if sold as research substances. We ship to France but buyers should verify their institution's import policy.

• ANSM may classify peptides as médicaments if physiological effect can be demonstrated.
• Semaglutide is a prescription médicament in France — we do not sell it as a product to France.
• Institutional buyers (universities, labs) typically have import clearance frameworks in place.
• Private individuals ordering peptides face the highest regulatory scrutiny.

Spain's AEMPS (Agencia Española de Medicamentos y Productos Sanitarios) regulates medicines. Research peptides not listed as controlled substances and not marketed as medicines are generally importable for laboratory use. Spain has a relatively clear research exemption for scientific institutions.

• AEMPS regulates medicines — not compounds explicitly sold for laboratory research only.
• No specific peptide scheduling in Spanish law outside of approved medicines.

AIFA (Agenzia Italiana del Farmaco) governs pharmaceutical products in Italy. Research peptides sold strictly for laboratory use are not classified as medicinal products. Customs may hold shipments for inspection.

• AIFA jurisdiction applies to medicinal products — research materials fall outside this scope.
• Customs delays occur occasionally; documentation of research use is recommended.

Sweden's Läkemedelsverket (Medical Products Agency) has one of the strictest interpretations in the EU. Many peptides that are freely available for research in other EU countries are classified as läkemedel (medicines) in Sweden. We ship only a limited subset of compounds to Sweden and strongly recommend buyers consult Swedish law before ordering.

• Läkemedelsverket has classified multiple research peptides as prescription medicines.
• Importation without prescription may constitute a criminal offence under Läkemedelslagen.
• GH-axis peptides (GHRH analogues, GHRPs) are particularly restricted.
• BPC-157, GHK-Cu, and NAD+ are generally unaffected by Swedish medicine law.

Austria's BASG (Bundesamt für Sicherheit im Gesundheitswesen) applies the Arzneimittelgesetz similar to Germany. Growth hormone secretagogues and GLP-1 analogues face stricter scrutiny. Research use for institutional labs is generally permitted.

• AMG classification may apply to peptides with pharmacological activity even without marketing as medicines.
• Semaglutide and Retatrutide require prescription in Austria — not sold for personal use.
• Research institutions can typically import under a research exemption.

Denmark's Lægemiddelstyrelsen (DKMA) regulates medicines. Most peptides sold as research materials are outside the scope of Danish pharmaceutical law. Denmark has historically been permissive regarding research chemical imports.

• Research compounds not scheduled under Danish law are freely importable for lab use.
• Approved drugs (Semaglutide) require prescription regardless.

Poland's Urząd Rejestracji applies EU pharmaceutical directives. Most research peptides fall outside the scope of medicine regulation when sold strictly for research. Poland has a well-developed scientific research sector and is a common destination for research compounds.

• No specific peptide scheduling beyond standard EU pharmaceutical law.
• Research use with institutional documentation is straightforward.

SUKL (State Institute for Drug Control) applies EU pharmaceutical directives. Research peptides not classified as medicines under SÚKL are importable for scientific research purposes.

• Standard EU pharmaceutical directive applies — research compounds not on SÚKL's medicine list are permissible.

Retatrutide

Melanotan II

Tesamorelin

HGH Somatropin

Oxytocin

BPC-157

TB-500 (Thymosin β4)

GHK-Cu

IGF-1 LR3

CJC-1295 (with/without DAC)

GHRP-2 / GHRP-6 / Ipamorelin

Semax / Selank

Sermorelin

MOTS-C

NAD+ (Nicotinamide Adenine Dinucleotide)